A Fitchburg company that is developing drugs to treat Alzheimer’s disease will get one year of free office space in University Research Park, valued at $80,000, and $20,000 in cash as the top finisher in the Governor’s Business Plan Contest. Mithridion Inc., formed in November 2004, is developing drugs based on discoveries at the University of Wisconsin-Madison on a protein in the brain that appears to halt the progression of Alzheimer’s. Trevor Twose, Mithridion’s chief executive officer, and Jeff Johnson, an associate professor in pharmaceutical sciences at UW-Madison, co-founded the company.
Office of Strategic Communication